| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7390677 | Value in Health Regional Issues | 2014 | 8 Pages |
Abstract
Results suggest that including PCV7 into the City Immunity Program in Shanghai could be considered cost-effective under generally accepted willingness-to-pay thresholds when both the direct and indirect effects of the vaccine are considered in the analysis.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Shanlian MS, Qiang MD, PhD, Shengfan MS, Lixia MS, Jiangjiang MS, Chieh-I MPH, Ronald PhD, Bruce PhD, Craig S. PharmD, MPA,